It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Tumor-initiating stem-like cells (TICs) are defective in maintaining asymmetric cell division and responsible for tumor recurrence. Cell-fate-determinant molecule NUMB-interacting protein (TBC1D15) is overexpressed and contributes to p53 degradation in TICs. Here we identify TBC1D15-mediated oncogenic mechanisms and tested the tumorigenic roles of TBC1D15 in vivo. We examined hepatocellular carcinoma (HCC) development in alcohol Western diet-fed hepatitis C virus NS5A Tg mice with hepatocyte-specific TBC1D15 deficiency or expression of non-phosphorylatable NUMB mutations. Liver-specific TBC1D15 deficiency or non-p-NUMB expression reduced TIC numbers and HCC development. TBC1D15–NuMA1 association impaired asymmetric division machinery by hijacking NuMA from LGN binding, thereby favoring TIC self-renewal. TBC1D15–NOTCH1 interaction activated and stabilized NOTCH1 which upregulated transcription of NANOG essential for TIC expansion. TBC1D15 activated three novel oncogenic pathways to promote self-renewal, p53 loss, and Nanog transcription in TICs. Thus, this central regulator could serve as a potential therapeutic target for treatment of HCC.
Normal stem cells are maintained by asymmetric cell division, but this process is dysregulated in tumour initiating stem-like cells (TICs). Here, the authors show that TBC1D15 impairs the asymmetric division machinery and activates NOTCH pathway for TIC self-renewal and expansion to promote liver tumorigenesis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Southern California, Department of Molecular Microbiology and Immunology, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
2 University of Southern California, Department of Molecular Microbiology and Immunology, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); Aligarh Muslim University, Section of Genetics, Department of Zoology, Aligarh, India (GRID:grid.411340.3) (ISNI:0000 0004 1937 0765)
3 University of Southern California, Department of Chemistry and Biological Sciences, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
4 University of Southern California, Department of Molecular Microbiology and Immunology, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); University of Connecticut Health, Department of Genetics and Genomics, and The Jackson Laboratory for Genomic Medicine, Farmington, USA (GRID:grid.208078.5) (ISNI:0000000419370394)
5 University of Southern California, Department of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
6 University of Southern California, Department of Surgery, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
7 Saint Louis University, St. Louis, USA (GRID:grid.262962.b) (ISNI:0000 0004 1936 9342)
8 University of Southern California, Department of Pathology, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); Southern California Research Center for ALPD and Cirrhosis, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); VA Greater Los Angeles Healthcare System, Los Angeles, USA (GRID:grid.417119.b) (ISNI:0000 0001 0384 5381)
9 University of Southern California, Department of Molecular Microbiology and Immunology, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853); Southern California Research Center for ALPD and Cirrhosis, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)